Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Novartis
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The First Affiliated Hospital with Nanjing Medical University
Swedish Medical Center
Merck Sharp & Dohme LLC